Cinvanti 47426-0201-01

Generic: Aprepitant

Package NDC

47426-0201-01

Manufacturer: Heron Therapeutics, Inc.
Dosage Form: Injection, Emulsion
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: January 3, 2018
Listing Expires: December 31, 2027
Application: NDA209296

Need to source Cinvanti? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Aprepitant	130 mg/18mL

Drug Class

Substance P/Neurokinin-1 Receptor Antagonist [EPC]Cytochrome P450 2C9 Inducers [MoA]Cytochrome P450 3A4 Inducers [MoA]

Selected Package

47426-0201-01Selected

1 VIAL, GLASS in 1 CARTON (47426-201-01) / 18 mL in 1 VIAL, GLASS